Brief: Rallybio Q2 Net Income USD -18.63 Million
08/08/2023 13:00
Aug 08 (Reuters) - Rallybio Q2 operating expenses USD 20.083 million. * Q2 income from operations USD -20.083 million * Q2 basic EPS USD -0.46
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx